Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Unknown 3Completed 3Terminated 2

Sponsor Class

OTHER 3NETWORK 2NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia 1Head and Neck Neoplasms 1Erectile Dysfunction 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × Erythropoietin × Clear all
NCT00737893 2021-04-08

ERECT

Johns Hopkins University

Phase 2 Completed
56 enrolled 27 charts
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

NCT01467115 2017-05-09

DREXNECK

Drexel University

Phase 2 Completed
1 enrolled
Head & Neck

Head and Neck Neoplasms

NCT01099202 2012-08-27

Procrit Versus No Procrit in Acute Lymphocytic Leukemia, Lymphoblastic Lymphoma, or Burkitt's Undergoing Induction/Consolidation Chemotherapy

M.D. Anderson Cancer Center

Phase NA Completed
109 enrolled 7 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡